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Marı́a C. Camilión de Hurtado, and Horacio E. Cingolani
Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina
Submitted 1 December 2004; accepted in final form 26 January 2005
Ennis, Irene L., Carolina D. Garciarena, Néstor G. Pérez, Raúl
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Myocardial stretch elicits a biphasic increase in developed force with
a first rapid force response and a second slow force response (SFR).
The rapid phase is due to an increase in myofilament Ca2 respon-
siveness; the SFR, analyzed here, is ascribed to a progressive increase
in Ca2 transients. Experiments were performed in cat papillary
muscles to further elucidate the signaling pathway underlying the
SFR. Although the SFR was diminished by BQ-123, a similar endo-
thelin (ET)-1-induced increase in force was not affected: 23  2 vs.
23  3% (not significant). Instead, BQ-123 suppressed the contractile
effects of ET-2 or ET-3 (21  2 and 25  3% vs. 1  1 and 7 
3% respectively, P  0.05), suggesting that ET-2 or ET-3, but not
ET-1, was involved in the SFR. Each isoform activated the Na/H
exchanger (NHE-1), increasing intracellular Na concentration by
2.0  0.1, 2.3  0.1, and 2.1  0.4 mmol/l for ET-1, ET-2, and ET-3,
respectively (P  0.05). The NHE-1 inhibitor HOE-642 prevented the
increases in force and intracellular Na concentration induced by all
the ET isoforms, but only ET-2 and ET-3 effects were sensitive to
BQ-123. Real-time RT-PCR measurements of prepro-ET-1, -ET-2,
and -ET-3 were performed before and 5, 15, and 30 min after stretch.
No changes in ET-1 or ET-2, but an increase of 60% in ET-3,
mRNA after 15 min of stretch were detected. Stretch-induced ET-3
mRNA upregulation and its mechanical counterpart were suppressed
by AT1 receptor blockade with losartan. These data suggest a role for
AT1-mediated ET-3 released in the early activation of NHE-1 that
follows myocardial stretch.
myocardial contractility; signal transduction; endothelin isoforms;
sodium/hydrogen exchanger-1
IT WAS SHOWN BY Von Anrep (30) in 1912 that the dilatation of
the heart induced by clamping the heart outflow was followed
by a decline in heart volume toward the initial value. Later,
Rosenblueth et al. (26) called attention to the fact that an
increase in heart rate (Bowditch effect), as well as an increase
in afterload (Anrep effect), triggered increases in contractility
of the isolated canine right ventricle, which they named “the
two-staircase phenomenon.” Sarnoff et al. (28) in 1960 coined
the term “homeometric autoregulation” to define the increase
in contractility elicited by the Bowditch and Anrep phenom-
ena. In 1973, Parmley and Chuck (23) were the first to
reproduce the contractile effect of stretch in isolated strips of
ventricular myocardium. They showed that when the muscle
length was abruptly increased, there were corresponding rapid
and slow increases in developed force. The rapid change in
force is thought to be the basis of the Frank-Starling mecha-
nism and is induced by an increase in myofilament Ca2
responsiveness. The slow force response (SFR) develops in the
next 10–15 min, and it is due to a progressive increase in the
Ca2 transient (1, 3, 17, 24). The source for this increase in
Ca2 remained unexplained until we proposed the activation of
the Na/H exchanger (NHE-1) as the cause for its production
(3, 7, 8, 24). Studies in multicellular cardiac muscle prepara-
tions from cat, rabbit, rat, and failing human heart have
provided evidence that the stretch induces a rise in intracellular
Na concentration ([Na]i) through NHE-1 activation. The
increase in [Na]i causes an increase in the Ca2 transient
through reverse-mode Na/Ca2 exchange (NCX) (3, 24).
Consistent with this proposed chain of events, the SFR was
abolished by NHE-1 inhibition and reverse-mode NCX block-
ade (3, 24). Activation of NHE-1 was the result of an auto-
crine-paracrine loop involving the release of preformed angio-
tensin II (ANG II), which triggers the release/formation of
endothelin (ET) (8). However, although a role of ET, but not
ANG II, was confirmed in ferret papillary muscles by Calaghan
and White (5), other investigators were not able to confirm this
in rabbit (31) or failing human heart (32), challenging our
proposed chain of events.
One intriguing finding that invited us to consider that ET-1
was probably not the isoform involved in the chain of events
that follow myocardial stretch was the resistance of the positive
inotropic effect of ET-1 to the ETA-specific blocker BQ-123
demonstrated in the studies of Kasai et al. (15).
Three ET isopeptides (ET-1, ET-2, and ET-3) encoded by
independent genes have been identified. Most of the cardiac
effects of ET seem to be produced by ET-1, although the other
two isoforms are also expressed in the heart. Endoh and
colleagues (12) reported that the three isoforms elicit a positive
inotropic effect, essentially with identical efficacies and poten-
cies in the myocardium. However, although the effect of ET-1
was resistant to BQ-123, the effect of ET-3 was not (12, 15).
Because the SFR was affected by BQ-123 (3, 5 ,24), we
wonder whether ET-3, and not ET-1, was the isoform released
by stretch. Experiments were undertaken to examine the role of
ET isoforms in the SFR that follows myocardial stretch.
METHODS
This investigation conforms to the National Institutes of Health
Guide for the Care and Use of Laboratory Animals (NIH Publication
No. 85-23, revised 1996). All experiments were conducted in accor-
dance with institutional guidelines, and the Institutional Animal Care
and Use Committee at Universidad Nacional de La Plata approved the
experimental protocol. The experiments were performed in cat pap-
illary muscles from the right ventricle mounted and superfused as
previously described (24). After they were mounted, the muscles were
progressively stretched to determine the length at which they devel-
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oped the maximal twitch force (Lmax). For the experiments in which
the inotropic effects of ET-1, ET-2, or ET-3 were studied, the muscles
were maintained at 98% of Lmax (L98) throughout the protocol (30
min of incubation with each peptide in the absence and presence of the
ETA receptor blocker BQ-123 at 300 nmol/l). Changes in [Na]i were
monitored as previously described (3, 24). For the stretch protocols,
the muscles were set at 92% of Lmax (L92) and randomly assigned to
one of the following protocols: 1) 30 min at L92, i.e., nonstretched
muscles, 2) 30 min at L92 and 5, 15, or 30 min at L98, 3) 10 min at L92
plus 20 min at L92 in the presence of 1 mol/l losartan (an AT1
receptor blocker) followed by 15 min of stretch to L98, 4) 30 min at
L92, 15 min of stretch to L98, and 10 min of shortening to L92 for 10
min followed by incubation with BQ-123 for 20 more min and then 15
min of stretch to L98. At the end of protocols 1–3, the superfusion
solution was quickly replaced by RNA stabilization reagent (RNA-
later, Qiagen) to freeze mRNA content for later determination. Total
RNA was isolated from papillary muscles using the RNeasy kit
(Qiagen). RNA (0.8 g) was reverse transcribed using the Omniscript
RT kit (Qiagen). A dilution of the resulting cDNA was used to
quantify the relative content of mRNA by real-time PCR (iCycler iQ
real-time PCR detection system, Bio-Rad) using appropriate primers
and SYBR Green as the fluorescent probe. The following primers,
designed using Primer3 software, were used: 5-GGGTGTGAAC-
CACGAGAAAT-3 (forward) and 5-CCACAGTCTTCTGAGTG-
GCA-3 (reverse) for GAPDH, 5-CAGACAAAGAACTCCGAG-
CC-3 (forward) and 5-GGTCTTGATGCTGTTGCTGA-3 (reverse)
for prepro-ET-1, 5-CTCTCCTGGGACGCTAACTG-3 (forward)
and 5-GGATGGCCTCTCTTGTCAAC-3 (reverse) for prepro-
ET-2, and 5-TCTCCACAGACACGCTTACG-3 (forward) and 5-
TGACTTCAGCCTTTGACGTG-3 (reverse) for prepro-ET-3. PCR
were performed with Platinum Taq DNA polymerase (Invitrogen).
Fluorescence data were acquired at the end of extension. A melt
analysis was run for all products to determine the specificity of the
amplification. The cycle threshold values for each gene were mea-
sured and calculated by computer software (iCycler IQ OSS, version
3.0a, Bio-Rad).
Statistics. Values are means  SE. Statistical analysis of results
was performed with Student’s t-test or ANOVA followed by the
Student-Newman-Keuls post hoc test as appropriate. Significance
level was set at P  0.05.
RESULTS
Figure 1 shows the SFR to stretch and the effect of blocking
the ETA receptors with BQ-123 in cat papillary muscles. As in
previous reports (3, 24, 31), after 10–15 min, the SFR reached
a steady-state value that was  20% higher than the initial
rapid phase. It was previously demonstrated by us (3, 24) and
others (2, 17) that the SFR is the result of a gradual increase in
Ca2 transients. The increase in Ca2 transient amplitude is
due to the NCX driven into its reverse mode by the increase in
[Na]i produced by ET activation of the NHE-1 (3, 24).
According to reports from others (5) and from our laboratory
(3, 24), a significant diminution of the SFR was observed in the
presence of the selective ETA antagonist BQ-123 (Fig. 1).
Although ET-1 is the most studied ET isoform and its
stimulation of ETA receptors is widely accepted, it is known
that the positive inotropic effect of this peptide is resistant to
most of the available ET receptor blockers, either the nonse-
lective receptor blockers that are supposed to block ETA and
ETB receptors or the combination of selective ETA and ETB
blockers (12, 15). However, this pharmacological feature of
ET-1 was not considered by us when we described the effect
of BQ-123 on the SFR. This apparently simple finding that
the SFR was blunted by BQ-123, whereas the effect of ET-1
was resistant to this compound, suggested to us that an ET
isoform other than ET-1 might be responsible for NHE-1
activation.
As a first step to identify the isoform participating in
development of the SFR, we carried out experiments in
which an increase in force similar in magnitude to the SFR
was mimicked by exogenous ET-1, ET-2, and ET-3, and
their corresponding sensitivity to BQ-123 was explored. In
pilot experiments, we found that the three isoforms were
similar in efficacy and potency, in agreement with previous
reports (12).
When the increase in force was promoted by ET-1 (5.0
nmol/l), the positive inotropic effect was not affected by 300
nmol/l BQ-123 (Fig. 2). In contrast, when the SFR was mim-
icked by ET-2 or ET-3 (5.0 nmol/l each), the increase in force
was abolished by BQ-123 (Figs. 3 and 4, respectively). Inter-
estingly, the time course of the contractile response to myo-
cardial stretch (Fig. 1) was better represented by exogenous
ET-3 (Fig. 4) than ET-2 (Fig. 3) or ET-1 (Fig. 2).
Given the fact that the increase in [Na]i mediated by
ET-induced NHE-1 stimulation is mandatory for the contractile
response to stretch by favoring the NCX reverse mode of
operation (3, 24) and that there was no evidence of the possible
effects of ET-2 and ET-3 on NHE-1 activity, experiments were
performed to explore whether these peptides were also able to
activate the NHE-1, increasing [Na]i and, consequently, pro-
ducing the positive inotropic effect. Figure 5 shows that similar
increases in [Na]i and force were induced by ET-1, ET-2, and
ET-3, demonstrating that the three isoforms were also equipo-
tent in terms of NHE-1 activation. Figure 5 also shows that
NHE-1 inhibition with 1 mol/l HOE-642 canceled the in-
Fig. 1. A: stretch of cat papillary muscles from 92% of muscle length at
maximum twitch force (Lmax, L92) to 98% of Lmax (L98) promotes characteristic
biphasic response in force. Initial rapid phase was followed by the slow force
response (SFR), which stabilized after 10–15 min at 20% greater than the
initial rapid phase. B: representative experiment in which stretching protocol
was performed in the presence of BQ-123 (300 nmol/l). SFR was almost
canceled by BQ-123, confirming participation of endogenous endothelin (ET)
in development of SFR. C: averaged results obtained under experimental
conditions described in A and B. SFR is expressed as percentage of initial rapid
phase [developed force (DF)]. Values are means  SE; n  4. *P  0.05 vs.
initial rapid phase. #P  0.05 vs. control.
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creases in [Na]i and force, indicating that, at this dose, the
positive inotropic effect of each ET isoform is entirely medi-
ated by NHE-1 activation and the subsequent rise in [Na]i.
Interestingly, the blockade of ETA receptors with BQ-123 did
not cancel the ET-1 effect on NHE-1 but completely sup-
pressed the effect of ET-2 and ET-3 (Fig. 5). The lack of
prevention of NHE-1 activation by this concentration of BQ-
123 after this concentration of ET-1 is in agreement with the
lack of blockade by this compound of the contractile response
to ET-1 and further supports the notion that ET-1 was not the
isoform involved in generation of the SFR.
We hypothesized that an indirect way to distinguish which
isoform could be involved in the SFR would be to examine, at
different times after stretch, the relative abundance of the
mRNA of the three isoforms. The rationale for this hypothesis
is based on the assumption that the release/formation of a
specific ET isoform immediately after stretch may be followed
by an increase in its mRNA abundance to restore the intracel-
lular pool. Therefore, a new set of experiments was carried out
in which prepro-ET-1, -ET-2, and -ET-3 mRNAs were as-
sessed by real-time RT-PCR before stretch (nonstretched mus-
cles) and 5, 15, and 30 min after stretch. RT-PCR was used to
corroborate expression of all three ET isoforms in cat papillary
muscles. In accordance with a previous report (14), more
amplification cycles were necessary to detect ET-2 than ET-1
and ET-3 in our preparation. Figure 6A shows the average
values of the prepro-ET mRNA measurements. Prepro-ET-3
mRNA increased 60% after 15 min of stretch and returned
toward prestretch values after 30 min. No change in the amount
of the other two prepro-ET isoform mRNAs was detected at 5,
15, or 30 min. Our previous experiments in cat papillary
muscles indicated that, in the chain of events leading to the
SFR, activation of the AT1 receptors is upstream of the release/
formation of ET. Along with our proposal that AT1 receptors
would be upstream of ET upregulation, another set of experi-
ments exploring the effect of AT1 receptor blockade on the
prepro-ET mRNA profile was performed. The specific block-
ade of AT1 receptors prevents the increase in prepro-ET-3
mRNA without affecting prepro-ET-1 and -ET-2 mRNA levels
(Fig. 6B). Consistent with these results, the SFR was com-
pletely abolished in this group of papillary muscles: 1  1%
(n  4) and 24  1% (n  8) in the presence and absence of
losartan, respectively (P  0.05). These data, therefore, con-
firm our proposal that the cross talk between the AT1 receptors
and ET-3 is a necessary step in induction of the SFR in this
preparation.
Fig. 2. A: after 30 min, addition of ET-1 (5 nmol/l) to a papillary muscle
promoted an increase in DF similar in magnitude to that of SFR. B: experiment
similar to A, but in the presence of 300 nmol/l BQ-123, a maneuver that did not
prevent the increase in DF promoted by ET-1. C: averaged results of DF
(expressed as percentage of pre-ET-1 value) after 30 min of incubation under
experimental conditions described in A and B (without and with BQ-123).
Values are means  SE; n  7 for ET-1 and n  5 for ET-1  BQ-123. *P 
0.05 vs. before ET-1.
Fig. 3. A and B: representative experiments after addition of 5 nmol/l ET-2.
Protocol is the same as in Fig. 2, except BQ-123 canceled the increase in DF.
C: averaged results of DF after 30 min of incubation under experimental
conditions described in A and B (without and with BQ-123). Values are
means  SE; n  4. *P  0.05 vs. before ET-2.
Fig. 4. A: the increase in DF after addition of 5 nmol/l ET-3 to a papillary
muscle was of a similar magnitude to that obtained after addition of the same
concentration of ET-1 and ET-2; thus similar to the SFR. B: similar to ET-2,
BQ-123 canceled the increase in DF. C: averaged results of DF after 30 min
of incubation under experimental conditions described in A and B (without and
with BQ-123). Values are means  SE; n  5. *P  0.05 vs. pre-ET-3 control.
#P  0.05 vs. ET-3.
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The experiments presented here represent the first evidence
of a role of ET-3 in the myocardial response to stretch. In our
multicellular preparation, myocardial stretch activates the tis-
sue renin-angiotensin-endothelin system by releasing ANG II
or by directly activating AT1 receptors, leading to the
release/formation of ET-3, which subsequently activates the
NHE-1 and increases [Na]i. Figure 7 depicts our hypothetical
autocrine-paracrine chain of events that follows myocardial
stretch.
Because exogenously applied ET-1, in concentrations that
mimic the inotropic effect of the SFR, was not affected by
BQ-123, it was difficult to accept that ET-1 could be involved
in this chain of events. Although we do not have direct
measurements of the ET isoform released by stretch, the
transient increase in prepro-ET-3 mRNA detected 15 min after
stretch, without significant changes in the other two isoforms,
suggested a role for ET-3 in development of the SFR. It can
result in a surprising rapid increase in the level of mRNA and
its return to basal values in 30 min. However, it has been
reported that the half-life of prepro-ET-1 mRNA is 10 min
(11), and a similar pattern of transient elevation of prepro-ET-1
mRNA has been described for the hypertrophic effect of
exogenous ET-3 in neonatal rat myocytes (29). The measure-
ment at the protein level itself would be stronger evidence of
the isoform involved if the ET isoform is “de novo” synthe-
sized before being released. However, the time required for the
formation of ET is probably beyond the time scale of our
experiments (30 min). If we consider that the levels of ET
may represent the spillover from the surrounding tissue with a
short half-life, mRNA measurements are probably a reliable
tool. This indirect approach allowed us to detect the mRNA
upregulation of only the ET-3 isoform. We would like to
emphasize that we measured ET mRNA abundance as an index
of the restoration of the intracellular pool from which ET is
released after myocardial stretch. This pool needs to be replen-
ished after the preformed ET is released, inducing an increase
in its mRNA. It can be argued that ET-1 or ET-2 mRNA could
increase at a time different from the times examined by us;
however, the fact that the mechanical effect was sensitive to
BQ-123 and that BQ-123 blunted ET-3-induced, but not ET-
1-induced, NHE-1 activation strongly supports the idea that
ET-3 is the specific isoform involved in development of the
SFR. More direct evidence of the isoform involved would
probably require that the experiments be performed under
specific inhibition of each isoform or that each isoform be
genetically antagonized. Unfortunately, no compound is capa-
ble of specifically antagonizing each ET isoform, and tech-
Fig. 5. ET-1, ET-2, and ET-3 induced similar increases in
intracellular Na concentration ([Na]i) and force (n  5, 3,
and 4, respectively), demonstrating that ET isoforms are equi-
potent. Increases in [Na]i and force were canceled by block-
ade of Na/H exchanger (NHE-1) with HOE-642 (n  3 for
ET-1 and ET-2 and n  4 for ET-3), indicating that, at this
dose, positive inotropic effect of each ET isoform is entirely
due to NHE-1 activation. Blockade of ETA receptors with
BQ-123 did not cancel ET-1 effect on NHE-1 (n  3) but
completely suppressed effects of ET-2 and ET-3 (n  3 and 4,
respectively). *P  0.05 vs. pre-ET stimulated values.
Fig. 6. A: significant increase in expression of prepro-ET-3
mRNA ( 60%) after 15 min of stretch (n  6) but no change
in expression of prepro ET-1 and -ET-2 mRNAs at any time
(n  7 and 4, respectively) compared with nonstretched mus-
cles (nsm, n  4). B: ANG II AT1 receptor blockade with
losartan (1 mol/l, Los) completely abolished increase in pre-
pro-ET-3 mRNA induced by myocardial stretch without affect-
ing prepro-ET-1 and -ET-2 mRNAs (n  4). *P  0.05 vs.
nsm.
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niques to genetically manipulate ET expression in the hearts
from which papillary muscles are being isolated are not avail-
able to us.
The fact that myocardial stretch induces the release of ANG
II and ET is well known since pioneering studies by Sadoshima
et al. (27) and Yamazaki et al. (33), who showed that mechan-
ical stretch of cultured neonatal rat cardiomyocytes caused the
release of preformed ANG II to the surrounding medium and
that the peptide acted as the initial stimulus of the stretch-
induced hypertrophic response. The release of ANG II trig-
gered by stretch was also demonstrated in adult cardiomyo-
cytes by Leri et al. (19). Moreover, Liang and Gardner (20),
studying the expression of the brain natriuretic peptide gene
induced by mechanical stretch of cultured neonatal myocytes,
found that it was completely blocked by AT1 receptor blockade
with losartan or by blockade of ETA receptors, implying a role
for ANG II and ET as autocrine/paracrine mediators. These
authors also found that ANG II and ET were arrayed in series,
because the effect of ANG II was cancelled by ET receptor
blockade, whereas the effect of ET was unaffected by AT1
blockade (20). Previous studies from our laboratory in feline
papillary muscles also showed that the cross talk between ANG
II and ET follows the same direction, because ANG II effects
were suppressed by ET receptor blockade while effects of
exogenously applied ET-1 were insensitive to blockade of AT1
receptors with losartan (8, 25). Although a recent study chal-
lenged the release of ANG II after myocardial stretch in the
necessary amount to stimulate the AT1 receptors, conforma-
tional changes of these receptors induced by the stretch itself
seem to be able to trigger intracellular pathways that are also
prevented by AT1 blockade (35).
Species-dependent variations in the positive inotropic effect
of ET-3 that have been previously reported (34) could probably
account for the fact that the role of ET in development of the
SFR was confirmed in the rat (3), cat (24), and ferret (5), but
not rabbit (31), myocardium. Nor was involvement of ET
detected in the failing human myocardium (32); however, we
are not aware of reports in normal human hearts. Although the
source of the ET released after myocardial stretch remains
controversial (5, 24), endothelial/endocardial cells could be the
source of ET-3. If this were the case, the injury of these cells
during some experimental protocols could be another explana-
tion for the discrepancies. However, the presence of the SFR
along with stretch has been reported in isolated cardiomyocytes
by two different groups of investigators (4, 13).
Although the stimulation of myocardial NHE-1 by ET-1 is a
well-known fact (6, 18, 22), the effect of ET-2 and ET-3 on the
exchanger has been less explored (16). We demonstrated here
that ET-1, ET-2, and ET-3 stimulate the NHE-1 and increase
[Na]i in a similar magnitude. The rise in [Na]i entirely
accounts for the positive inotropic effect of each isopeptide.
However, only the rise in [Na]i induced by ET-2 and ET-3
was cancelled by the concentration of BQ-123 selected here,
perhaps as a reflection of the participation of different subtypes
of ET receptors, as previously suggested (12, 21).
Myocardial stretch has been widely analyzed as one of the
main causes of cardiac hypertrophy, particularly in neonatal rat
cardiomyocytes, and the role of the ANG II-ET-aldosterone
system in this phenomenon was demonstrated. On the other
hand, myocardial response to stretch in multicellular prepara-
tions has been also extensively studied in regard to the Frank-
Starling mechanism and two phases of the contractile response.
However, the possibility that both myocardial responses to
stretch resulted from the same intracellular signaling pathway
was not considered until the finding that the SFR, the in vitro
mechanical counterpart of the Anrep effect, was the result of an
autocrine-paracrine loop triggered by the sequential activation
of AT1 receptors, the release of ET, and the activation of
NHE-1 (Fig. 7) (10). Moreover, the possible link between the
SFR and myocardial hypertrophy is supported by the fact that
the chronic and specific blockade of the NHE-1 was shown to
effectively regress cardiac hypertrophy in several experimental
models (see Ref. 9 for review).
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H2929ENDOTHELIN-3 AND MYOCARDIAL STRETCH
AJP-Heart Circ Physiol • VOL 288 • JUNE 2005 • www.ajpheart.org
 on M







1. Allen DG and Kentish JC. The cellular basis of the length-tension
relationship in cardiac muscle. J Mol Cell Cardiol 17: 821–840, 1985.
2. Allen DG and Kurihara S. The effects of muscle length on intracellular
calcium transients in mammalian cardiac muscle. J Physiol 327: 79–94,
1982.
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25. Pérez NG, Villa-Abrille MC, Aiello EA, Dulce RA, Cingolani HE, and
Camilión de Hurtado MC. A low dose of angiotensin II increases
inotropism through activation of reverse Na/Ca2 exchange by endothe-
lin release. Cardiovasc Res 60: 589–597, 2003.
26. Rosenblueth A, Alanais J, Lopez E, and Rubio R. The adaptation of
ventricular muscle to different circulatory conditions. Arch Int Physiol
Biochem 67: 358–373, 1959.
27. Sadoshima J, Xu Y, Slayter HS, and Izumo S. Autocrine release of
angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes
in vitro. Cell 75: 977–984, 1993.
28. Sarnoff SJ, Mitchell JH, Gilmore JP, and Remensnyder JP. Homeo-
metric autoregulation in the heart. Circ Res 8: 1077–1091, 1960.
29. Tamamori M, Ito H, Adachi S, Akimoto H, Marumo F, and Hiroe M.
Endothelin-3 induces hypertrophy of cardiomyocytes by the endogenous
endothelin-1-mediated mechanism. J Clin Invest 97: 366–372, 1996.
30. Von Anrep G. On the part played by the suprarenals in the normal
vascular reactions on the body. J Physiol 45: 307–317, 1912.
31. Von Lewinski D, Stumme B, Maier LS, Luers C, Bers DM, and Pieske
B. Stretch-dependent slow force response in isolated rabbit myocardium is
Na dependent. Cardiovasc Res 57: 1052–1061, 2003.
32. Von Lewinski D, Stumme B, Fialka F, Luers C, and Pieske B.
Functional relevance of the stretch-dependent slow force response in
failing human myocardium. Circ Res 94: 1392–1398, 2004.
33. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno
T, Maemura K, Kurihara H, Aikawa R, Takano H, and Yazaki Y.
Endothelin-1 is involved in mechanical stress-induced cardiomyocyte
hypertrophy. J Biol Chem 271: 3221–3228, 1996.
34. Yang HT, Zhu Y, and Endoh M. Species-dependent differences in
inotropic effects and phosphoinositide hydrolysis induced by endothelin-3
in mammalian ventricular myocardium. Br J Pharmacol 120: 1497–1504,
1997.
35. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita
N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M,
Nagai T, Fukamizu A, Umemura S, Iiri T, Fujita T, and Komuro I.
Mechanical stress activates angiotensin II type 1 receptor without the
involvement of angiotensin II. Nat Cell Biol 6: 499–506, 2004.
H2930 ENDOTHELIN-3 AND MYOCARDIAL STRETCH
AJP-Heart Circ Physiol • VOL 288 • JUNE 2005 • www.ajpheart.org
 on M
ay 4, 2006 
ajpheart.physiology.org
D
ow
nloaded from
 
